dc.creator | Binvignat O. | |
dc.creator | Olloquequi J. | |
dc.date.accessioned | 2020-09-02T22:13:11Z | |
dc.date.accessioned | 2022-11-08T20:19:07Z | |
dc.date.available | 2020-09-02T22:13:11Z | |
dc.date.available | 2022-11-08T20:19:07Z | |
dc.date.created | 2020-09-02T22:13:11Z | |
dc.date.issued | 2020 | |
dc.identifier | 26, 12, 1251-1262 | |
dc.identifier | 13816128 | |
dc.identifier | https://hdl.handle.net/20.500.12728/3764 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5143017 | |
dc.language | en | |
dc.publisher | Bentham Science Publishers | |
dc.subject | Alzheimer’s disease | |
dc.subject | Calcium | |
dc.subject | ER stress | |
dc.subject | Glutamate | |
dc.subject | Neurodegeneration | |
dc.subject | Neuroinflammation | |
dc.subject | Oxidative stress | |
dc.subject | Parkinson’s disease | |
dc.subject | adenosine triphosphatase | |
dc.subject | amino acid | |
dc.subject | apoptosome | |
dc.subject | apoptotic protease activating factor 1 | |
dc.subject | BH3 protein | |
dc.subject | calcium | |
dc.subject | calcium channel blocking agent | |
dc.subject | calpain | |
dc.subject | caspase 9 | |
dc.subject | cinnarizine | |
dc.subject | DNA | |
dc.subject | flunarizine | |
dc.subject | glutamic acid | |
dc.subject | glyceraldehyde 3 phosphate dehydrogenase | |
dc.subject | inositol 1,4,5 trisphosphate receptor | |
dc.subject | ion channel | |
dc.subject | ionotropic receptor | |
dc.subject | isoflurane | |
dc.subject | lomerizine | |
dc.subject | memantine | |
dc.subject | n methyl dextro aspartic acid receptor | |
dc.subject | nimodipine | |
dc.subject | nitric oxide | |
dc.subject | propofol | |
dc.subject | reactive oxygen metabolite | |
dc.subject | reduced nicotinamide adenine dinucleotide phosphate oxidase | |
dc.subject | sodium calcium exchange protein | |
dc.subject | unindexed drug | |
dc.subject | verapamil | |
dc.subject | zonisamide | |
dc.subject | Alzheimer disease | |
dc.subject | amyotrophic lateral sclerosis | |
dc.subject | apoptosis | |
dc.subject | calcium homeostasis | |
dc.subject | cell death | |
dc.subject | cytotoxicity | |
dc.subject | degenerative disease | |
dc.subject | dementia | |
dc.subject | disease exacerbation | |
dc.subject | disorders of mitochondrial functions | |
dc.subject | DNA fragmentation | |
dc.subject | dopaminergic nerve cell | |
dc.subject | endoplasmic reticulum stress | |
dc.subject | excitotoxicity | |
dc.subject | frontotemporal dementia | |
dc.subject | human | |
dc.subject | Huntington chorea | |
dc.subject | in vitro study | |
dc.subject | in vivo study | |
dc.subject | inflammation | |
dc.subject | mitochondrial permeability | |
dc.subject | molecular mechanics | |
dc.subject | motor performance | |
dc.subject | nerve degeneration | |
dc.subject | nervous system inflammation | |
dc.subject | nitrosylation | |
dc.subject | oxidative stress | |
dc.subject | Parkinson disease | |
dc.subject | pathophysiology | |
dc.subject | priority journal | |
dc.subject | protein processing | |
dc.subject | Review | |
dc.subject | traumatic brain injury | |
dc.subject | unfolded protein response | |
dc.title | Excitotoxicity as a target against neurodegenerative processes | |
dc.type | Review | |